Hereditary Nonpolyposis Colon Cancer
Watchlist
Retrieved
2021-01-23
Source
Trials
—
Genes
MSH2,
MLH1,
PMS2,
MSH6,
MLH3,
EPCAM,
TGFBR2,
FAN1,
APC,
KRAS,
PMS1,
MSH3,
EXO1,
PALB2,
CHEK2,
ATM,
PIK3CA,
CDH1,
PTPRJ,
CTNNA1,
CD44,
EPHX1,
CDKN1B,
NFKBIZ,
SMARCA4,
BARD1,
SEMA4A,
XRCC4,
RPS20,
MUTYH
MSH2,
MLH1,
PMS2,
MSH6,
MLH3,
EPCAM,
TGFBR2,
FAN1,
APC,
KRAS,
PMS1,
MSH3,
EXO1,
PALB2,
CHEK2,
ATM,
PIK3CA,
CDH1,
PTPRJ,
CTNNA1,
CD44,
EPHX1,
CDKN1B,
NFKBIZ,
SMARCA4,
BARD1,
SEMA4A,
XRCC4,
RPS20,
MUTYH,
FBXO11,
CTNNB1,
BRCA2,
MRC1,
BRCA1,
BRAF,
TP53,
PTEN,
FAP,
CDKN2A,
CCND1,
RINT1,
PTGS2,
H3P10,
CD274,
REEP5,
NHS,
BAX,
BAAT,
SMAD4,
NAT2,
STK11,
COX2,
IGF1,
MTHFR,
HRAS,
POLE,
HDAC2,
ARID1A,
MTCO2P12,
XRCC6P5,
PMS2CL,
ARSA,
CEACAM5,
RAD51C,
GSTT1,
CYP1A1,
MYC,
BRIP1,
EGFR,
POLD1,
GSTM1,
GSTP1,
LRRFIP2,
XPA,
ANXA10,
VHL,
RASSF1,
TIMP2,
AIP,
TGFB1,
SOCS1,
CTCF,
RNF43,
SEC63,
EMB,
MIR18B,
MIR31,
MIR23B,
MIR223,
MIR152,
MIR148A,
LINC01194,
GSTK1,
ARSI,
CISD3,
HEPACAM,
SLCO6A1,
MUC16,
ZHX2,
ATAD1,
STN1,
MYH14,
CPAT1,
NLRP2,
CDHR2,
CDHR5,
F11R,
SGSM3,
NPTN,
GREM1,
SPEN,
ZEB1,
NAT1,
ST8,
SPTBN1,
KAT2A,
FMR1,
ETS1,
ERCC2,
ERBB2,
EPHB1,
ENG,
ELK3,
DNMT3B,
DCC,
CYP17A1,
CYP1B1,
CTLA4,
KLF6,
COMT,
COL11A2,
CEACAM7,
CEACAM3,
CDX2,
CASP2,
BLM,
APEX1,
APBA1,
ALK,
AKT1,
PARP1,
ACVR2A,
GJA8,
HFE,
IGF2,
PCNA,
SPRR2A,
SLC6A2,
RNASEL,
RAF1,
PTPRG,
PSG2,
MAP2K7,
PRB1,
PIK3CG,
PIK3CD,
PIK3CB,
SERPINA1,
NDUFAB1,
IGF2R,
NBN,
MMP7,
MMP1,
MGMT,
MEN1,
MDM2,
MCC,
MAX,
MAT2A,
SMAD7,
SMAD2,
ITGA9,
PDCD1
Drugs
—
Registered!
A cancer-predisposing condition characterized by the development of colorectal cancer not associated with colorectal polyposis, endometrial cancer, and various other cancers (such as malignant epithelial tumor of ovary, gastric, biliary tract, small bowel, and urinary tract cancer) that are frequently diagnosed at an early age.